GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gilead Sciences Inc (LIM:GILD) » Definitions » Shiller PE Ratio

Gilead Sciences (LIM:GILD) Shiller PE Ratio : 19.79 (As of May. 07, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Gilead Sciences Shiller PE Ratio?

As of today (2025-05-07), Gilead Sciences's current share price is $110.25. Gilead Sciences's E10 for the quarter that ended in Mar. 2025 was $5.57. Gilead Sciences's Shiller PE Ratio for today is 19.79.

The historical rank and industry rank for Gilead Sciences's Shiller PE Ratio or its related term are showing as below:

LIM:GILD' s Shiller PE Ratio Range Over the Past 10 Years
Min: 9.93   Med: 13.75   Max: 58.16
Current: 17.3

During the past years, Gilead Sciences's highest Shiller PE Ratio was 58.16. The lowest was 9.93. And the median was 13.75.

LIM:GILD's Shiller PE Ratio is ranked better than
70.23% of 524 companies
in the Drug Manufacturers industry
Industry Median: 24.24 vs LIM:GILD: 17.30

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Gilead Sciences's adjusted earnings per share data for the three months ended in Mar. 2025 was $1.040. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $5.57 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Gilead Sciences Shiller PE Ratio Historical Data

The historical data trend for Gilead Sciences's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gilead Sciences Shiller PE Ratio Chart

Gilead Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.58 12.80 13.87 12.26 15.79

Gilead Sciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.78 11.26 13.98 15.79 19.80

Competitive Comparison of Gilead Sciences's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Gilead Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gilead Sciences's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gilead Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Gilead Sciences's Shiller PE Ratio falls into.


;
;

Gilead Sciences Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Gilead Sciences's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=110.25/5.57
=19.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gilead Sciences's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Gilead Sciences's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=1.04/134.9266*134.9266
=1.040

Current CPI (Mar. 2025) = 134.9266.

Gilead Sciences Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 2.920 100.684 3.913
201509 3.060 100.392 4.113
201512 3.180 99.792 4.300
201603 2.530 100.470 3.398
201606 2.580 101.688 3.423
201609 2.490 101.861 3.298
201612 2.340 101.863 3.100
201703 2.050 102.862 2.689
201706 2.330 103.349 3.042
201709 2.060 104.136 2.669
201712 -2.960 104.011 -3.840
201803 1.170 105.290 1.499
201806 1.390 106.317 1.764
201809 1.600 106.507 2.027
201812 0.002 105.998 0.003
201903 1.540 107.251 1.937
201906 1.470 108.070 1.835
201909 -0.920 108.329 -1.146
201912 2.120 108.420 2.638
202003 1.220 108.902 1.512
202006 -2.660 108.767 -3.300
202009 0.290 109.815 0.356
202012 1.230 109.897 1.510
202103 1.370 111.754 1.654
202106 1.210 114.631 1.424
202109 2.050 115.734 2.390
202112 0.300 117.630 0.344
202203 0.020 121.301 0.022
202206 0.910 125.017 0.982
202209 1.420 125.227 1.530
202212 1.300 125.222 1.401
202303 0.800 127.348 0.848
202306 0.830 128.729 0.870
202309 1.730 129.860 1.798
202312 1.140 129.419 1.189
202403 -3.340 131.776 -3.420
202406 1.290 132.554 1.313
202409 1.000 133.029 1.014
202412 1.420 133.157 1.439
202503 1.040 134.927 1.040

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Gilead Sciences  (LIM:GILD) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Gilead Sciences Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Gilead Sciences's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Gilead Sciences Business Description

Address
333 Lakeside Drive, Foster City, CA, USA, 94404
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).